Image-guided interventional surgery firm Stereotaxis of St. Louis has received clearance from the U.S. Food and Drug Administration (FDA) to market its Navistar RMT Thermocool catheter.
The device, manufactured by Biosense Webster of Diamond Bar, CA, is used with Stereotaxis' Niobe remote magnetic navigation system for mapping and radiofrequency ablation to treat irregular heartbeats.
Stereotaxis expects to begin shipments of the catheter within the next few weeks.
Related Reading
Stereotaxis launches Odyssey Cinema, October 23, 2008
Stereotaxis reaches Niobe milestone, May 1, 2008
Stereotaxis adds to executive lineup, April 7, 2008
Stereotaxis appoints new CMO, January 17, 2008
Stereotaxis reports continued growth for Q3, November 8, 2007
Copyright © 2009 AuntMinnie.com